The Cochrane Library: Cochrane Database of Systematic Reviews

Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
    1. About this group
    2. Reviews
      1. Abdominal lift for laparoscopic cholecystectomyReview
      2. Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis BReview
      3. Anabolic-androgenic steroids for alcoholic liver diseaseReview
      4. Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patientsReview
      5. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleedingReview
      6. Antibiotic prophylaxis for leptospirosisReview
      7. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatographyReview
      8. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomyReview
      9. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleedingReview
      10. Antibiotics for leptospirosisReview
      11. Antibiotics for preventing leptospirosisReviewWithdrawn
      12. Antibiotics for spontaneous bacterial peritonitis in cirrhotic patientsReview
      13. Antibiotics for treating leptospirosisReviewWithdrawn
      14. Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver diseaseReview
      15. Antioxidant supplements for liver diseasesReview
      16. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisReview
      17. Antioxidant supplements for preventing gastrointestinal cancersReview
      18. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesReview
      19. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantationReview
      20. Antiviral therapy for recurrent liver graft infection with hepatitis C virusReview
      21. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusReview
      22. Artificial and bioartificial support systems for liver failureReview
      23. Azathioprine for primary biliary cirrhosisReview
      24. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adultsReview
      25. Bariatric surgery for non-alcoholic steatohepatitis in obese patientsReview
      26. Benzodiazepine receptor antagonists for hepatic encephalopathyReview
      27. Bezafibrate for primary biliary cirrhosisReview
      28. Bicyclol for chronic hepatitis BReview
      29. Bicyclol for chronic hepatitis CReview
      30. Bile acids for liver-transplanted patientsReview
      31. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitisReview
      32. Bile acids for primary sclerosing cholangitisReview
      33. Bile acids for viral hepatitisReview
      34. Bisphosphonates for osteoporosis in primary biliary cirrhosisReview
      35. Booster dose vaccination for preventing hepatitis BReview
      36. Branched-chain amino acids for hepatic encephalopathyReview
      37. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipientsReview
      38. Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resectionReview
      39. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infectionReview
      40. Chinese medicinal herbs for chronic hepatitis BReview
      41. Chlorambucil for patients with primary biliary cirrhosisReview
      42. Cholecystectomy deferral in patients with endoscopic sphincterotomyReview
      43. Cholecystectomy for gallbladder polypReview
      44. Cholecystectomy for patients with silent gallstonesReview
      45. Cholecystectomy for suspected gallbladder dyskinesiaReview
      46. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosisReview
      47. Colchicine for primary biliary cirrhosisReview
      48. Cryotherapy for hepatocellular carcinomaReview
      49. Cyclosporin A for primary biliary cirrhosisReview
      50. Cyclosporin versus tacrolimus for liver transplanted patientsReview
      51. D-penicillamine for primary biliary cirrhosisReview
      52. D-penicillamine for primary sclerosing cholangitisReview
      53. Day-case versus overnight stay for laparoscopic cholecystectomyReview
      54. Dopaminergic agonists for hepatic encephalopathyReview
      55. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisReviewWithdrawn
      56. Early versus delayed laparoscopic cholecystectomy for acute cholecystitisReview
      57. Early versus delayed laparoscopic cholecystectomy for biliary colicReview
      58. Elective surgery for benign liver tumoursReview
      59. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patientsReview
      60. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stonesReview
      61. Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgeryReview
      62. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patientsReview
      63. Glucocorticosteroids for primary biliary cirrhosisReview
      64. Glucocorticosteroids for primary sclerosing cholangitisReview
      65. Glucocorticosteroids for viral hepatitis CReview
      66. Hepatitis A immunisation in persons not previously exposed to hepatitis AReview
      67. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothersReview
      68. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure statusReview
      69. Hepatitis B vaccination for patients with chronic renal failureReview
      70. Hormone replacement for osteoporosis in women with primary biliary cirrhosisReview
      71. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesReview
      72. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscessReview
      73. Immunoglobulins for preventing hepatitis AReview
      74. Interferon alpha for chronic hepatitis DReview
      75. Interferon for acute hepatitis CReview
      76. Interferon for interferon naive patients with chronic hepatitis CReview
      77. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CReview
      78. Interventions for paracetamol (acetaminophen) overdoseReview
      79. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusionReview
      80. Ischaemic preconditioning for liver transplantationReview
      81. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationReview
      82. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaReview
      83. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasisReview
      84. Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasisReview
      85. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastasesReview
      86. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomyReview
      87. Medicinal herbs for hepatitis C virus infectionReview
      88. Methods of cystic duct occlusion during laparoscopic cholecystectomyReview
      89. Methods of decreasing infection to improve outcomes after liver resectionsReview
      90. Methods of preventing bacterial sepsis and wound complications for liver transplantationReview
      91. Methods of vascular occlusion for elective liver resectionsReview
      92. Methods of vascular occlusion for elective liver resectionsReviewWithdrawn
      93. Methods to decrease blood loss and transfusion requirements for liver transplantationReview
      94. Methotrexate for primary biliary cirrhosisReview
      95. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseasesReview
      96. Miniport versus standard ports for laparoscopic cholecystectomyReview
      97. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinomaReview
      98. Nonabsorbable disaccharides for hepatic encephalopathyReview
      99. Nutritional interventions for liver-transplanted patientsReview
      100. Nutritional support for liver diseaseReview
      101. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviewsReviewOverview
      102. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumoursReview
      103. Pentoxifylline for alcoholic hepatitisReview
      104. Percutaneous needle aspiration, injection, and re-aspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cystsReview
      105. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaReview
      106. Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular controlReview
      107. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resectionReview
      108. Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular controlReview
      109. Phyllanthus species for chronic hepatitis B virus infectionReview
      110. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infectionReviewNew
      111. Piggy-back graft for liver transplantationReview
      112. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosisReview
      113. Pre-operative biliary drainage for obstructive jaundiceReview
      114. Primary closure versus T-tube drainage after laparoscopic common bile duct stone explorationReview
      115. Primary closure versus T-tube drainage after open common bile duct explorationReview
      116. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitisReview
      117. Probiotics for patients with hepatic encephalopathyReview
      118. Propylthiouracil for alcoholic liver diseaseReview
      119. Prostaglandins for adult liver transplanted patientsReview
      120. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinomaReview
      121. Ribavirin monotherapy for chronic hepatitis CReview
      122. Ribavirin plus interferon versus interferon for chronic hepatitis CReview
      123. Ribavirin with or without alpha interferon for chronic hepatitis CReviewWithdrawn
      124. Robot assistant versus human or another robot assistant in patients undergoing laparoscopic cholecystectomyReview
      125. Routine abdominal drainage for uncomplicated laparoscopic cholecystectomyReview
      126. Routine abdominal drainage for uncomplicated liver resectionReview
      127. Routine abdominal drainage for uncomplicated open cholecystectomyReview
      128. Routine drainage for orthotopic liver transplantationReview
      129. S-adenosyl-L-methionine for alcoholic liver diseasesReview
      130. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis BReview
      131. Small-incision versus open cholecystectomy for patients with symptomatic cholecystolithiasisReview
      132. Somatostatin analogues for acute bleeding oesophageal varicesReview
      133. Sphincterotomy for biliary sphincter of Oddi dysfunctionReview
      134. Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastasesReview
      135. Surgical versus endoscopic treatment of bile duct stonesReview
      136. Tamoxifen for hepatocellular carcinomaReview
      137. Techniques for liver parenchymal transection in liver resectionReview
      138. Techniques of flushing and reperfusion for liver transplantationReview
      139. Terlipressin for acute esophageal variceal hemorrhageReview
      140. Terlipressin for hepatorenal syndromeReview
      141. Three dimensional versus two dimensional imaging for laparoscopic cholecystectomyReview
      142. TIPS versus paracentesis for cirrhotic patients with refractory ascitesReview
      143. Transarterial (chemo)embolisation for unresectable hepatocellular carcinomaReview
      144. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastasesReviewNew Search
      145. Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusionReview
      146. Ursodeoxycholic acid for primary biliary cirrhosisReview
      147. Vaccines for preventing hepatitis B in health-care workersReview
      148. Vascular occlusion for elective liver resectionsReview
      149. Veno-venous bypass versus none for liver transplantationReview
      150. Virtual reality training for surgical trainees in laparoscopic surgeryReview
      151. Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseasesReview
      152. Weight reduction for non-alcoholic fatty liver diseaseReview
    3. Protocols
      1. Acupuncture for chronic hepatitis B virus infectionProtocol
      2. Adefovir dipivoxil for chronic hepatitis BProtocol
      3. Adefovir dipivoxil for chronic hepatitis BProtocol
      4. Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis BProtocol
      5. Albumin and other plasma expanders for paracentesis treatment of ascites in cirrhotic patientsProtocol
      6. Aminoadamantanes for chronic hepatitis CProtocol
      7. Antibiotic prophylaxis for surgical site infection in patients undergoing liver transplantationProtocol
      8. Antibiotics for cholangitis and/or cholecystitisProtocol
      9. Antibiotics for hepatic encephalopathyProtocol
      10. Antibody induction versus corticosteroid induction for liver transplant recipientsProtocol
      11. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsProtocol
      12. Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patientsProtocol
      13. Beta-blocker plus nitrates for secondary prevention of variceal bleedingProtocol
      14. Beta-blockers alone or with endoscopic therapy for prevention of variceal rebleeding in portal hypertensionProtocol
      15. Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patientsProtocol
      16. Bile acids for biliary colicProtocol
      17. Capsule endoscopy for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisProtocolDiagnostic
      18. Celsior solution versus University of Wisconsin solution in liver preservation for transplantationProtocol
      19. Chemotherapy for gallbladder cancerProtocol
      20. Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancerProtocol
      21. Comparison of medicinal herbs for chronic hepatitis B virus infectionProtocol
      22. Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipientsProtocol
      23. Cryotherapy for liver metastasesProtocol
      24. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisProtocolNew
      25. Education of patients about to undergo laparoscopic cholecystectomyProtocol
      26. Electro-coagulation for liver metastasesProtocol
      27. Emergency sclerotherapy or band ligation combined with vasoactive drugs for bleeding esophageal varices in cirrhosisProtocol
      28. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in patients with portal hypertensionProtocol
      29. Endoscopic interventions for unresectable cholangiocarcinomaProtocol
      30. Entecavir for chronic hepatitis BProtocol
      31. Erythrocytapheresis versus phlebotomy for hereditary haemochromatosisProtocol
      32. Foscarnet for chronic hepatitis BProtocol
      33. Glucocorticosteroids for alcoholic hepatitisProtocol
      34. Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomyProtocol
      35. Glucocorticosteroids for liver transplanted patientsProtocol
      36. Glucocorticosteroids for patients undergoing laparoscopic cholecystectomyProtocol
      37. Glucocorticosteroids for viral hepatitis BProtocol
      38. Glycyrrhizin for chronic hepatitis B virus infectionProtocol
      39. Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infectionProtocol
      40. Granulocyte-colony stimulating factor for acute liver failure or acute-on-chronic liver failureProtocolNew
      41. Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantationProtocol
      42. Hepatitis B immune globulin for prevention of posttransplantation hepatitis BProtocol
      43. Hepatitis B immunoglobulin during pregnancy for the prevention of mother to child transmission of hepatitis B virusProtocol
      44. Herbal medicines for fatty liver diseasesProtocol
      45. Interferon alpha for chronic hepatitis BProtocol
      46. Interferon beta for chronic hepatitis BProtocol
      47. Interferon for hepatocellular carcinomaProtocol
      48. Interferon gamma for chronic hepatitis BProtocol
      49. Intra-peritoneal local anaesthetic instillation versus no intra-peritoneal local anaesthetic instillation for laparoscopic cholecystectomyProtocol
      50. Intra-peritoneal saline instillation versus no instillation for laparoscopic cholecystectomyProtocol
      51. Isoprinosine versus other antiviral drugs for chronic hepatitis BProtocolNew
      52. L-ornithine-L-aspartate for hepatic encephalopathyProtocol
      53. Lamivudine during pregnancy for preventing hepatitis B virus infection in newbornsProtocol
      54. Lamivudine for chronic hepatitis B in adultsProtocol
      55. Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapyProtocol
      56. Laparoscopic-endoscopic rendezvous versus preoperative endoscopic sphincterotomy for common bile duct stones in patients undergoing laparoscopic cholecystectomyProtocolNew
      57. Laparoscopic surgical box model training for surgical trainees with limited prior laparoscopic experienceProtocolNew
      58. Laparoscopic surgical box model training for surgical trainees with no prior laparoscopic experienceProtocolNew
      59. Laparoscopic versus open liver resection for benign and malignant hepatic lesions in adultsProtocol
      60. Levamisole for chronic hepatitis BProtocol
      61. Magnetic resonance imaging, computer tomography scan, and oesophagography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisProtocolDiagnostic
      62. Medical therapeutic agents for Wilson's diseaseProtocol
      63. Medical treatments for autoimmune hepatitisProtocol
      64. Medicinal herbs for acute hepatitis BProtocol
      65. Medicinal herbs for cholelithiasisProtocol
      66. Methods of gallbladder dissection for laparoscopic cholecystectomyProtocol
      67. Methods of intra-peritoneal local anaesthetic instillation for laparoscopic cholecystectomyProtocol
      68. Methods of management of high-risk surgical patients with acute cholecystitisProtocol
      69. Microwave coagulation for liver metastasesProtocol
      70. Mycophenolate mofetil for liver-transplanted patientsProtocol
      71. Naloxone for hepatic encephalopathyProtocol
      72. Nitazoxanide for chronic hepatitis C virus infectionProtocol
      73. Non-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisProtocolDiagnostic
      74. Non-pharmacological and pharmacological interventions for primary prevention of gallbladder stones in adultsProtocol
      75. Non-steroid anti-inflammatory drugs for biliary colicsProtocol
      76. Organic nitrates for prevention of esophageal varices bleeding and rebleedingProtocol
      77. Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis CProtocol
      78. Pegylated interferon for acute hepatitis CProtocol
      79. Pegylated interferon for chronic hepatitis BProtocol
      80. Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis CProtocol
      81. Percutaneous ethanol injection for liver metastasesProtocol
      82. Perfusion techniques for liver retrieval in liver donorsProtocol
      83. Pharmacological interventions for prevention or treatment of post-operative pain in patients undergoing laparoscopic cholecystectomyProtocol
      84. Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantationProtocol
      85. Phlebotomy for hereditary haemochromatosisProtocol
      86. Platelet count, spleen length, and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisProtocolDiagnostic
      87. Postexposure vaccines for hepatitis AProtocol
      88. Preoperative physical exercise training for patients scheduled for major abdominal surgeryProtocol
      89. Prostaglandin E1 analogues for chronic hepatitis BProtocol
      90. Selective vasopressin type 2 receptor antagonist for patients with cirrhosisProtocol
      91. Serological laboratory tests for diagnosis of human leptospirosis in patients presenting with clinical symptomsProtocolDiagnostic
      92. Sophorus species for chronic hepatitis B virus infectionProtocol
      93. Statins for non-alcoholic steatohepatitisProtocol
      94. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhageProtocol
      95. Surgical resection for hepatocellular carcinomaProtocol
      96. Surgical versus medical treatment of refractory ascitesProtocol
      97. Systemic chemotherapy for inoperable hepatocellular carcinomaProtocol
      98. Techniques of biliary reconstruction for liver transplantationProtocol
      99. Telbivudine for chronic hepatitis BProtocol
      100. Tests for diagnosis of common bile duct stonesProtocolDiagnostic
      101. Thymosin alpha1 for chronic hepatitis BProtocol
      102. Tiopronin for chronic hepatitis BProtocol
      103. Total portosystemic shunt versus shunts preserving portal venous hepatic perfusion for variceal haemorrhageProtocol
      104. Transient ultrasound elastography and magnetic resonance elastography for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisProtocolDiagnostic
      105. Two or three ports versus four ports for laparoscopic cholecystectomyProtocol
      106. Wound infiltration with local anaesthetic agents for laparoscopic cholecystectomyProtocol
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH